By choosing liver tumor cell lines with high migration rates, namely HepG2 and HUH7, migration assays using collagen-coated transwell inserts demonstrated a significantly decreased migration of tumor cells incubated with recombinant human IGFBP3 (Figure 5B). This evidence concerns the gene IGFBP3 and Neoplasm of the liver.